Budd-Chiari syndrome in a young female with factor V Leiden mutation: successful treatment with lepirudin, a direct thrombin inhibitor

Thromb Res. 2008;121(6):769-72. doi: 10.1016/j.thromres.2007.08.008. Epub 2007 Oct 24.

Authors

Birgitta Salmela¹, Arno Nordin, Matti Vuoristo, Heikki Mäkisalo, Kirsti Numminen, Riitta Lassila

Affiliation

¹ Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland.

PMID: 17928037
DOI: 10.1016/j.thromres.2007.08.008

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anticoagulants / administration & dosage
Antithrombins / administration & dosage*
Budd-Chiari Syndrome / drug therapy*
Budd-Chiari Syndrome / genetics*
Cholecystitis / complications
Disease Progression
Drug Resistance
Drug-Related Side Effects and Adverse Reactions
Factor V / genetics*
Female
Follow-Up Studies
Hirudins / administration & dosage*
Humans
Infusions, Intravenous
Injections, Subcutaneous
Mutation
Odds Ratio
Recombinant Proteins / administration & dosage
Thrombophilia / complications
Thrombophilia / genetics*
Treatment Outcome

Substances

Anticoagulants
Antithrombins
Hirudins
Recombinant Proteins
factor V Leiden
Factor V
lepirudin